Rioquímica

What Rioquímica does

Rioquímica S.A. is a privately held Brazilian pharmaceutical and specialty chemical manufacturer founded in 1979 and headquartered in São José do Rio Preto, São Paulo. The company develops, produces and commercializes antiseptics, disinfectants and sanitizing solutions primarily for healthcare settings — spanning chlorhexidine digluconate formulations (Riohex, Rio Hands Scrub), alcohol-based hand hygiene products (Riocare Foam), hydrogen peroxide / quaternary ammonium disinfectant wipes (Oxirio Wipes), high-level instrument disinfectants (Rioscope OPA) and skin-protection products (Rioderm Protection). Its operations are organized into two internal product divisions — CCI (Cuidados Críticos Intensivos / Intensive Critical Care) and DPI (Divisão de Prevenção de Infecções / Infection Prevention) — and four go-to-market segments: Hospitalar (hospitals), Farmacêutico (hospital pharmacies and active pharmaceutical ingredients / IFA), Odontológico (dental clinics) and Veterinário (veterinary clinics). Manufacturing runs from a single industrial plant in São José do Rio Preto under GMP Brasil, ANVISA, ISO 9001 and ISO 13485 certifications.

Rioquímica sells B2B to healthcare institutions in Brazil through a segmented network of regional representatives organized by vertical, with international reach via local distributor partnerships — notably Hospinet in Colombia — and active participation in industry congresses such as MEDICA (Düsseldorf) and the III Congreso Nacional de Reprocesamiento de Dispositivos Médicos (Pereira, Colombia). Pricing is quote-based and not publicly disclosed; the company has ~51–100 employees and reports no public revenue. Revenue mechanics are one-time product sales (antiseptics, disinfectants, sanitizers, medical devices) under brands including Riohex, Riocare, Oxirio, Rioscope and Rioquímica, supplemented by transaction fees flowing through regional representatives and third-party e-commerce platforms such as Magazinemedica.com.br.

The company's strategic posture is that of a mature, regulation-anchored Brazilian manufacturer extending beyond its domestic base. Its 45-year operating history, GPTW-certified workplace and IP portfolio (registered trademarks across the Riohex, Rio Hands Scrub, Riocare, Oxirio, Rioderm, Rioscope and Rioquímica brands) provide intangible moats, while an expanded international conference footprint (notably MEDICA 2025) and formalized partnerships (Hospinet, 2025-11) point to an internationalization push. There is no disclosed funding, no parent company, and no AI/ML capability flagged in the available data.

Name

Rioquímica

Legal name

Rioquímica S.A.

Website

https://rioquimica.com.br

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

251–500 employees

Short description

Rioquímica is a privately held Brazilian pharmaceutical and chemical manufacturer, founded in 1979 in São José do Rio Preto, producing GMP- and ANVISA-certified antiseptics, disinfectants and sanitizing solutions for hospitals, hospital pharmacies, dental clinics and veterinary clinics in Brazil and select international markets.

Ownership category

akta.pro rank

Headquarters

HQ city

São José do Rio Prêto

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. B2B Healthcare Products Sales: Rioquímica generates revenue through direct B2B sales of antiseptic, disinfectant, and sanitizing products to healthcare institutions including hospitals, pharmaceutical companies, dental clinics, and veterinary clinics. Products include antiseptics, disinfectants, sanitizers, and medical devices under brands like Riohex, Riocare, and Oxirio.
2. Regional Representative Network: Sales through an organized network of regional representatives covering Brazil and international markets, organized by business segment. Representatives handle local institutional relationships and distribution.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Rioquímica develops, produces, and commercializes antiseptic, disinfectant, and sanitizing products for healthcare settings. The portfolio spans two main divisions — Cuidados Críticos Intensivos (CCI) for skin preparation, pressure injury prevention, catheter care, body hygiene, and wound cleaning, and Divisão de Prevenção de Infecções (DPI) for hand hygiene, surface disinfection, and instrument sterilization — sold under brands including Riohex, Rio Hands Scrub, Riocare, Oxirio, Rioscope, and Rioderm to hospitals, pharmacies, dental clinics, and veterinary clinics.

Product overview

Rioquímica is a 100% Brazilian pharmaceutical and chemical industry founded in 1979, specializing in the development, production, and commercialization of sanitizers, antiseptics, and pharmaceutical products. The company operates two main product divisions: CCI (Cuidados Críticos Intensivos / Intensive Critical Care) focused on skin preparation, wound care, and patient safety in critical care settings; and DPI (Divisão de Prevenção de Infecções / Infection Prevention Division) covering hand hygiene, surface disinfection, and instrument sterilization. Rioquímica serves four market segments: Hospitalar (hospitals and health institutions), Farmacêutico (pharmaceutical inputs including IFA and antiseptics), Odontológico (dental clinics), and Veterinário (veterinary clinics). Key products include the Rio Hands Scrub surgical hand antiseptic, Riocare Foam hand sanitizer, Riohex 2% tincture preparations, Oxirio Wipes disinfectant wipes, Rioscope OPA high-level disinfectant, and the Rioderm Protection line of skin barrier and protective film products. All products are manufactured under strict GMP practices with ANVISA certification.

Differentiator

Problem solved

Functional benefit

Products and services

• Oxirio Wipes Intermediate-level disinfectant wipes for fixed surfaces, non-critical articles, and equipment cleaning and disinfection. Contains hydrogen peroxide (0.5% w/w) and quaternary ammonium (0.4% w/w), effective from 1 minute contact time even in the presence of organic matter. Sold for use in healthcare, dental, and clinical environments.
• Rio Hands Scrub Surgical antiseptic for preparation of hands and forearms prior to surgical and invasive procedures. Contains 1% chlorhexidine digluconate with a blend of ethyl and isopropyl alcohols, emollients, and vitamin B5 (D-pantenol), providing an 8-hour residual effect for surgical hand preparation.
• Riocare Foam Antiseptic foam for hand and forearm hygiene with 70% ethyl alcohol and emollients for prolonged skin hydration. High-yield formula with wide hand coverage, effective against Candida Auris. Sold for healthcare worker hand hygiene.
• Riohex 2% Tinctura Prep Topical antiseptic with 2% chlorhexidine digluconate in alcoholic solution with dye, including sterile sponge applicator. Indicated for surgical site antisepsis and preoperative skin preparation, providing 6–8 hour residual effect.
• Rioscope OPA High-level disinfectant for semi-critical medical and dental articles. Ready-to-use, colorless, fragrance-free, neutral pH, non-corrosive, and biodegradable. Indicated for heat-sensitive articles using manual or automated disinfection systems.
• Riohex 2% Esponja de Banho Bath sponge with 0.02% chlorhexidine digluconate for preoperative hygiene and surgical procedures. Sold to hospitals for patient preoperative bathing protocols.
• Rioderm Protection Creme Barreira Skin barrier cream that protects skin against body fluids from incontinence, with hydration technology of up to 56 hours. Sold for use in hospitals, long-term care, and home care settings.
• Rioderm Protection Película Protetora Transparent cutaneous protective film that shields skin from exudate and body fluids and reduces the risk of adhesive-related injuries. Sold for hospital and clinical skin protection protocols.

Quantifiable outcome

• 100% customer satisfaction rating achieved with Rede Meridional across all evaluated hospital units in October 2025

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and minor.

• HospinetcoreChannel Partner/ Reseller/ Distributor · 6 November 2025Hospinet serves as Rioquímica's local partner and distributor in Colombia, facilitating market entry and distribution in the Colombian healthcare market. The partnership was highlighted during Rioquímica's participation in the III Congreso Nacional de Reprocesamiento de Dispositivos Médicos in Pereira, Colombia in November 2025, where Hospinet and Rioquímica exhibited together with a 12m² stand.
• Mariol EmbalagensminorOthersRelated company providing packaging solutions, mentioned in footer links alongside internal company systems.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Market position

Weaknesses5 records

Competitive moat4 records

Customer concentration

• YouTubeyoutube.com/@rioquimicas.a6270
• Facebookfacebook.com/rioquimica
• LinkedInlinkedin.com/company/rioquimica-sa
• Instagraminstagram.com/rioquimica.sa

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rioquímica